Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00222352 · ClinicalTrials.gov registry record
Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Testing on Outcomes
A clinical trial, sponsored by University of Cincinnati.
- Completed
- Registry status
- 2,000
- Enrollment target
NCT00222352: Completed study, sponsored by University of Cincinnati.
NCT00222352 is a clinical trial that has completed, run by University of Cincinnati. The registered enrollment target is 2,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00222352 has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- 2,000 participants
- Enrollment target
Study Summary
In a randomized, controlled clinical trial, point-of care testing at the bedside using the cardiac biomarker troponin I in ED patients with possible ACS will be compared to traditional testing of this assay for myocardial necrosis obtained in the central laboratory. Our hypothesis: point-of-care testing for troponin I will decrease the time for disposition of patients with possible ACS in the emergency setting and decrease the time required for administering appropriate therapies for these patients.
Primary Outcome
The primary hypotheses are that i) POC testing using the i-STAT system reduces the time to disposition and discharge for low-risk patients being discharged directly from the ED, and ii) POC testing using the i-STAT system reduces the time to therapy compared to laboratory testing for the subset of patients requiring anti-thrombotic therapies such as heparin/LMW heparin or anti-platelet agents such as GPIIb/IIIa inhibitors or clopidogrel or PCI. These groups of patients (those with new ST-depress
Interventions
- DIAGNOSTIC_TEST Point of Care cTnL testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2004-12 |
| Est. Completion | 2007-03 |
What the finished NCT00222352 record still lists
NCT00222352 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Point of Care cTnL testing is the first listed.
NCT00222352 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00222352 about?
NCT00222352 is a clinical study titled "Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Testing on Outcomes". In a randomized, controlled clinical trial, point-of care testing at the bedside using the cardiac biomarker troponin I in ED patients with possible ACS will be compared to traditional testing of this assay for myocardial necrosis obtained in the central laboratory. Our hypothesis: point-of-care tes...
What is the current status of trial NCT00222352?
This trial is currently completed. The enrollment target is 2,000 participants. The study started on 2004-12. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00222352?
The interventions under investigation include: Point of Care cTnL testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT00222352?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia